Costales Abran

CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutations

S. Ramurthy, S. Subramanian, P. Amiri, 2006 .